Literature DB >> 10672031

Diverting a protein from its cellular location by intracellular antibodies. The case of p21Ras.

M Lener1, I R Horn, A Cardinale, S Messina, U B Nielsen, S M Rybak, H R Hoogenboom, A Cattaneo, S Biocca.   

Abstract

We describe the use of phage libraries to derive new antibodies against p21Ras to be used for intracellular expression in mammalian cells. A panel of single-chain antibody fragments, binding to Ras, were analyzed and characterized for their capacity to interfere in vitro with (a) the intrinsic GTPase activity of Ras and (b) the binding of Ras to its effector Raf, and were found not to neutralize its function, according to these biochemical criteria. When expressed intracellularly in mouse 3T3 K-Ras transformed cells all the anti-Ras single-chain variable fragments (scFv) tested inhibited cell proliferation, as assessed by bromodeoxyuridine incorporation. Double immunofluorescence analysis of transfected cells using confocal microscopy confirmed that anti-Ras antibody fragments colocalize with endogenous Ras, at subcellular locations where the protein Ras is not normally found. These data suggest that the ability of phage-derived anti-Ras scFv fragments to inhibit the function of Ras in vivo is a rather general and frequent property and that the range of antibodies that can be successfully used for intracellular inhibition studies is much greater than anticipated, exploiting the mode of action of diverting protein traffic.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10672031     DOI: 10.1046/j.1432-1327.2000.01125.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

Review 1.  The production and application of single-chain antibody fragments.

Authors:  D Blazek; V Celer
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

2.  Intrabody expression in eukaryotic cells.

Authors:  Laurence Guglielmi; Pierre Martineau
Journal:  Methods Mol Biol       Date:  2009

3.  A focused antibody library for selecting scFvs expressed at high levels in the cytoplasm.

Authors:  Pascal Philibert; Audrey Stoessel; Wei Wang; Annie-Paule Sibler; Nicole Bec; Christian Larroque; Jeffery G Saven; Jérôme Courtête; Etienne Weiss; Pierre Martineau
Journal:  BMC Biotechnol       Date:  2007-11-22       Impact factor: 2.563

4.  Characterization of antibodies in single-chain format against the E7 oncoprotein of the human papillomavirus type 16 and their improvement by mutagenesis.

Authors:  Maria Gabriella Donà; Colomba Giorgi; Luisa Accardi
Journal:  BMC Cancer       Date:  2007-01-31       Impact factor: 4.430

5.  Selection and characterisation of a phage-displayed human antibody (Fab) reactive to the lung resistance-related major vault protein.

Authors:  G L Scheffer; A W Reurs; B Jutten; S H W Beiboer; R van Amerongen; M Schoester; E A C Wiemer; H R Hoogenboom; R J Scheper
Journal:  Br J Cancer       Date:  2002-03-18       Impact factor: 7.640

6.  A novel intracellular antibody against the E6 oncoprotein impairs growth of human papillomavirus 16-positive tumor cells in mouse models.

Authors:  Carla Amici; Michela Visintin; Francesca Verachi; Francesca Paolini; Zulema Percario; Paola Di Bonito; Angela Mandarino; Elisabetta Affabris; Aldo Venuti; Luisa Accardi
Journal:  Oncotarget       Date:  2016-03-29

7.  A novel anti-p21Ras scFv antibody reacting specifically with human tumour cell lines and primary tumour tissues.

Authors:  Ju-Lun Yang; Du-Xian Liu; Shi-Jian Zhen; Yun-Gang Zhou; Dai-Jun Zhang; Li-Ying Yang; Hao-Bing Chen; Qiang Feng
Journal:  BMC Cancer       Date:  2016-02-20       Impact factor: 4.430

8.  Bacterial Inner-membrane Display for Screening a Library of Antibody Fragments.

Authors:  Parisa Moghaddam-Taaheri; Svetlana P Ikonomova; Zifan Gong; Janna Q Wisniewski; Amy J Karlsson
Journal:  J Vis Exp       Date:  2016-10-15       Impact factor: 1.355

9.  Elimination of TDP-43 inclusions linked to amyotrophic lateral sclerosis by a misfolding-specific intrabody with dual proteolytic signals.

Authors:  Yoshitaka Tamaki; Akemi Shodai; Toshifumi Morimura; Ryota Hikiami; Sumio Minamiyama; Takashi Ayaki; Ikuo Tooyama; Yoshiaki Furukawa; Ryosuke Takahashi; Makoto Urushitani
Journal:  Sci Rep       Date:  2018-04-16       Impact factor: 4.379

10.  An ultra-stable cytoplasmic antibody engineered for in vivo applications.

Authors:  Hiroyuki Kabayama; Makoto Takeuchi; Naoko Tokushige; Shin-Ichi Muramatsu; Miyuki Kabayama; Mitsunori Fukuda; Yoshiyuki Yamada; Katsuhiko Mikoshiba
Journal:  Nat Commun       Date:  2020-01-17       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.